{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:59:16Z","timestamp":1774184356293,"version":"3.50.1"},"reference-count":72,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Portuguese Foundation for Science and Technology (FCT)","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"Portuguese Foundation for Science and Technology (FCT)","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"Portuguese Foundation for Science and Technology (FCT)","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]},{"name":"CICS-UBI","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"CICS-UBI","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"CICS-UBI","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]},{"name":"Portuguese Platform of BioImaging (PPBI)","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"Portuguese Platform of BioImaging (PPBI)","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"Portuguese Platform of BioImaging (PPBI)","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]},{"name":"Agence Nationale de la Recherche","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"Agence Nationale de la Recherche","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"Agence Nationale de la Recherche","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]},{"name":"\u201cCentre National de la Recherche Scientifique\u201d (CNRS)","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"\u201cCentre National de la Recherche Scientifique\u201d (CNRS)","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"\u201cCentre National de la Recherche Scientifique\u201d (CNRS)","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]},{"name":"European Social Fund under the Regional Operational Program Centro","award":["UIDB\/00709\/2020"],"award-info":[{"award-number":["UIDB\/00709\/2020"]}]},{"name":"European Social Fund under the Regional Operational Program Centro","award":["UIDP\/00709\/2020"],"award-info":[{"award-number":["UIDP\/00709\/2020"]}]},{"name":"European Social Fund under the Regional Operational Program Centro","award":["ANR-21-CE18-0022-01"],"award-info":[{"award-number":["ANR-21-CE18-0022-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glioblastoma is the most prevalent and aggressive form of brain malignancy. Actual treatments face several challenges due to its high aggressiveness and poor prognosis. The chemotherapeutic agent temozolomide (TMZ) has limited therapeutic efficacy, and mutations in the tumour protein p53 gene (TP53) have been associated with treatment resistance. Thus, this study aimed to explore an innovative therapeutic strategy to enhance treatment efficacy of GBM. Previously, our team had developed a WRAP5 cell-penetrating peptide (CPP) functionalized with a transferrin receptor ligand (Tf) for the targeted delivery of TMZ and a p53-encoding plasmid to glioma cells. Our research had elucidated the circadian oscillations of the clock genes in the U87 glioma cells by employing two different computational models and observed that T16 and T8 time points revealed the highest circadian activity for Bmal1 and Per2 genes, respectively. Similar analysis was conducted for the transferrin receptor, which revealed that T7 and T8 were the key time points for its expression. A confocal microscopy study indicated the highest intracellular uptake of complexes and p53 mRNA expression at T8, the time point with the highest Per2 and transferrin receptor expression. Following mRNA analysis, the evaluation of p53 levels confirmed transcriptional changes at the protein level, and that T16 appears to be a favourable time point for enhancing therapeutic efficacy in U87 glioblastoma cells. These findings suggested that synchronizing the complexes\u2019 administration with the biological clock of GBM cells may significantly improve glioblastoma therapeutics.<\/jats:p>","DOI":"10.3390\/ijms26136130","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T06:55:13Z","timestamp":1750920913000},"page":"6130","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circadian-Tuned Peptide Drug\/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection"],"prefix":"10.3390","volume":"26","author":[{"given":"Ana R.","family":"Neves","sequence":"first","affiliation":[{"name":"RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-9641","authenticated-orcid":false,"given":"Eric","family":"Viv\u00e8s","sequence":"additional","affiliation":[{"name":"PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-1340","authenticated-orcid":false,"given":"Prisca","family":"Boisgu\u00e9rin","sequence":"additional","affiliation":[{"name":"PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-9858","authenticated-orcid":false,"given":"Telma","family":"Quintela","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"},{"name":"BRIDGES-Biotechnology Research, Innovation and Design for Health Products, Polytechnic University of Guarda, 6300-559 Guarda, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5049-4518","authenticated-orcid":false,"given":"Diana","family":"Costa","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Petkovi\u0107, M., Henis, M., Heese, O., and Rel\u00f3gio, A. (2023). Chronotherapy in Glioblastoma: State of the art and future perspectives. eBioMedicine, 89.","DOI":"10.1016\/j.ebiom.2023.104470"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00109-021-02106-x","article-title":"Exploring the link between chronobiology and drug delivery: Effects on cancer therapy","volume":"99","author":"Albuquerque","year":"2021","journal-title":"J. Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113571","DOI":"10.1016\/j.ejca.2024.113571","article-title":"Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study","volume":"199","author":"Catozzi","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/jcp.30815","article-title":"Circadian rhythm and disease: Relationship, new insights, and future perspectives","volume":"237","author":"Neves","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-neuro-100322-112249","article-title":"Circadian Rhythms and Astrocytes: The Good, the Bad, and the Ugly","volume":"46","author":"Hastings","year":"2023","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106322","DOI":"10.1016\/j.jddst.2024.106322","article-title":"Nanotechnology in glioblastoma therapy: Advances in drug delivery systems and diagnostic approaches","volume":"102","author":"Qindeel","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102187","DOI":"10.1016\/j.tranon.2024.102187","article-title":"Starting points for the development of new targeted therapies for glioblastoma multiforme","volume":"51","author":"Rusak","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Toader, C., Dumitru, A.V., Eva, L., Serban, M., Covache-Busuioc, R.A., and Ciurea, A.V. (2024). Nanoparticle Strategies for Treating CNS Disorders: A Comprehensive Review of Drug Delivery and Theranostic Applications. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413302"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wanis, H.A., M\u00f8ller, H., Ashkan, K., and Davies, E.A. (2024). Association of IDH1 Mutation and MGMT Promoter Methylation with Clinicopathological Parameters in an Ethnically Diverse Population of Adults with Gliomas in England. Biomedicines, 12.","DOI":"10.20944\/preprints202410.1135.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/clinpract12060108","article-title":"Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type","volume":"12","author":"Orasanu","year":"2022","journal-title":"Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.20892\/j.issn.2095-3941.2020.0179","article-title":"Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma","volume":"18","author":"Chai","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chien, C.-H., Hsueh, W.-T., Chuang, J.-Y., and Chang, K.-Y. (2021). Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-021-00717-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0748730417696788","article-title":"Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma","volume":"32","author":"Slat","year":"2017","journal-title":"J. Biol. Rhythm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11060-023-04535-9","article-title":"Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma","volume":"166","author":"Damato","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"vdab041","DOI":"10.1093\/noajnl\/vdab041","article-title":"Temozolomide chronotherapy in patients with glioblastoma: A retrospective single-institute study","volume":"3","author":"Damato","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1158\/2159-8290.CD-19-0215","article-title":"Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wagner, P.M., Fornasier, S.J., and Guido, M.E. (2024). Pharmacological Modulation of the Cytosolic Oscillator Affects Glioblastoma Cell Biology. Cell. Mol. Neurobiol., 44.","DOI":"10.1007\/s10571-024-01485-2"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Deguchi, S., Ohka, F., Shiba, Y., Yamaguchi, J., Sato, A., Shinjo, K., Arakawa, Y., Narita, Y., Kondo, Y., and Saito, R. (2025). Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13623-0"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/s41467-024-48416-9","article-title":"L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: Dose escalation of the phase I\/II GLORIA trial","volume":"15","author":"Giordano","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eabb3945","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference\u2013based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Meng, W., Huang, L., Guo, J., Xin, Q., Liu, J., and Hu, Y. (2024). Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121549"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123022","DOI":"10.1016\/j.ijpharm.2023.123022","article-title":"A nano-targeted co-delivery system based on gene regulation and molecular blocking strategy for synergistic enhancement of platinum chemotherapy sensitivity in ovarian cancer","volume":"640","author":"Song","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/10837450.2022.2149793","article-title":"Co-delivery of docetaxel and p53 gene from cationic nanoparticles based on poly (l-lactide) and low-molecular-weight polyethyleneimine (PEA)","volume":"27","author":"Guo","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1039\/D2TB01770A","article-title":"Synergistic effect of p53 gene\/DOX intracellular delivery and P-gp inhibition by pullulan thiomers on cancer cells: In vitro and in vivo evaluations","volume":"11","author":"Priya","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e39984","DOI":"10.1016\/j.heliyon.2024.e39984","article-title":"Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hani, U., Choudhary, V.T., Ghazwani, M., Alghazwani, Y., Osmani, R.A.M., Kulkarni, G.S., Shivakumar, H.G., Wani, S.U.D., and Paranthaman, S. (2024). Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121527"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2017.04.012","article-title":"PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo","volume":"256","author":"Aldrian","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Neves, A.R., Albuquerque, T., Faria, R., Gon\u00e7alves, A.M., Santos, C., Viv\u00e8s, E., Boisgu\u00e9rin, P., Passarinha, L.A., Sousa, \u00c2., and Costa, D. (2022). Development of WRAP5 Peptide Complexes for Targeted Drug\/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102213"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jconrel.2024.12.058","article-title":"Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles","volume":"378","author":"Koo","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"118789","DOI":"10.1016\/j.ijpharm.2019.118789","article-title":"Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment","volume":"572","author":"Jana","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Neves, A., Albuquerque, T., Faria, R., Santos, C.R.A., Viv\u00e8s, E., Boisgu\u00e9rin, P., Carneiro, D., Bruno, D.F., Pavlaki, M.D., and Loureiro, S. (2024). Evidence That a Peptide-Drug\/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16060781"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1534735419836494","DOI":"10.1177\/1534735419836494","article-title":"Analyses of BMAL1 and PER2 Oscillations in a Model of Breast Cancer Progression Reveal Changes With Malignancy","volume":"18","author":"Lin","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ramalho, M.J., Loureiro, J.A., Coelho, M.A.N., and Pereira, M.C. (2022). Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020279"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14191","DOI":"10.1021\/acsanm.3c02122","article-title":"Transferrin-Conjugated PLGA Nanoparticles for Co-Delivery of Temozolomide and Bortezomib to Glioblastoma Cells","volume":"6","author":"Ramalho","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/acs.bioconjchem.2c00389","article-title":"Transferrin Aptamers Increase the In Vivo Blood\u2013Brain Barrier Targeting of Protein Spherical Nucleic Acids","volume":"33","author":"Kusmierz","year":"2022","journal-title":"Bioconjugate Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-020-03527-3","article-title":"Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models","volume":"148","author":"Ni","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rosager, A.M., S\u00f8rensen, M.D., Dahlrot, R.H., Hansen, S., Schonberg, D.L., Rich, J.N., Lathia, J.D., and Kristensen, B.W. (2017). Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182954"},{"key":"ref_39","first-page":"916","article-title":"Transferrin receptor 1 in cancer: A new sight for cancer therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00018-015-2072-2","article-title":"Circadian mRNA expression: Insights from modeling and transcriptomics","volume":"73","author":"Westermark","year":"2016","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1038\/s41467-020-18115-2","article-title":"Circadian control of brain glymphatic and lymphatic fluid flow","volume":"11","author":"Hablitz","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"114380","DOI":"10.1016\/j.celrep.2024.114380","article-title":"Cell-specific regulation of the circadian clock by BMAL1 in the paraventricular nucleus: Implications for regulation of systemic biological rhythms","volume":"43","author":"Dai","year":"2024","journal-title":"Cell Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ajpath.2024.02.020","article-title":"Cryptochrome 2 Suppresses Epithelial-Mesenchymal Transition by Promoting Trophoblastic Ferroptosis in Unexplained Recurrent Spontaneous Abortion","volume":"194","author":"Li","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e14592","DOI":"10.1111\/cns.14592","article-title":"Cellular iron depletion enhances behavioral rhythm by limiting brain Per1 expression in mice","volume":"30","author":"Wu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1074\/jbc.M115.713412","article-title":"Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression","volume":"291","author":"Okazaki","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-10-0184","article-title":"Circadian Rhythm of Transferrin Receptor 1 Gene Expression Controlled by c-Myc in Colon Cancer\u2013Bearing Mice","volume":"70","author":"Okazaki","year":"2010","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bennett, C., Pettikiriarachchi, A., McLean, A.R.D., Harding, R., Blewitt, M.E., Seillet, C., and Pasricha, S.-R. (2023). Serum iron variation is circadian-regulated and linked to the harmonic circadian oscillations of erythropoiesis and hepatic Tfrc expression in mice. bioRxiv.","DOI":"10.1101\/2023.05.07.539729"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/ajh.27447","article-title":"Serum iron and transferrin saturation variation are circadian regulated and linked to the harmonic circadian oscillations of erythropoiesis and hepatic expression in mice","volume":"99","author":"Bennett","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"van der Spek, R., Fliers, E., la Fleur, S.E., and Kalsbeek, A. (2018). Daily Gene Expression Rhythms in Rat White Adipose Tissue Do Not Differ Between Subcutaneous and Intra-Abdominal Depots. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00206"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mo\u0161kon, M. (2020). CosinorPy: A python package for cosinor-based rhythmometry. BMC Bioinform., 21.","DOI":"10.1186\/s12859-020-03830-w"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mo\u0161kon, M. (2022). Identification and characterisation of variable rhythms using CosinorPy. bioRxiv.","DOI":"10.1101\/2022.07.04.498691"},{"key":"ref_52","first-page":"127","article-title":"Circadian Rhythms of Body Temperature and Locomotor Activity in Spontaneously Hypertensive Rats under Frequent Changes in Light Conditions","volume":"31","author":"Ryabinina","year":"2024","journal-title":"Pathophysiol. Off. J. Int. Soc. Pathophysiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Spick, M., Isherwood, C.M., Gethings, L.A., Hughes, C.J., Daly, M.E., Hassanin, H., van der Veen, D.R., Skene, D.J., and Johnston, J.D. (2025). Challenges and opportunities for statistical power and biomarker identification arising from rhythmic variation in proteomics. npj Biol. Timing Sleep, 2.","DOI":"10.1038\/s44323-024-00020-2"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shiba, A., de Goede, P., Tandari, R., Foppen, E., Korpel, N.L., Coopmans, T.V., Hellings, T.P., Jansen, M.W., Ruitenberg, A., and Ritsema, W.I.G.R. (2024). Synergy between time-restricted feeding and time-restricted running is necessary to shift the muscle clock in male wistar rats. Neurobiol. Sleep Circadian Rhythm., 17.","DOI":"10.1016\/j.nbscr.2024.100106"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cornelissen, G. (2014). Cosinor-based rhythmometry. Theor. Biol. Med. Model., 11.","DOI":"10.1186\/1742-4682-11-16"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"110245","DOI":"10.1016\/j.jneumeth.2024.110245","article-title":"CircadiPy: An open-source toolkit for analyzing chronobiology time series","volume":"411","author":"Passos","year":"2024","journal-title":"J. Neurosci. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Parsons, R., Jayasinghe, O., White, N., Chunduri, P., and Rawashdeh, O. (2024). GLMMcosinor: Flexible cosinor modeling with a generalized linear mixed modeling framework to characterize rhythmic time series. bioRxiv.","DOI":"10.32614\/CRAN.package.GLMMcosinor"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41531-022-00350-7","article-title":"Diurnal modulation of subthalamic beta oscillatory power in Parkinson\u2019s disease patients during deep brain stimulation","volume":"8","author":"Feldmann","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Motiei, M., Abu-Dawud, R., Rel\u00f3gio, A., and Assaf, C. (2024). Circadian rhythms in haematological malignancies: Therapeutic potential and personalised interventions. eBioMedicine, 110.","DOI":"10.1016\/j.ebiom.2024.105451"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.trecan.2023.11.002","article-title":"Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care","volume":"10","author":"Zhu","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"0612","DOI":"10.34133\/research.0612","article-title":"The Common Hallmarks of Aging, Circadian Rhythms and Cancer: Implications for Therapeutic Strategies","volume":"8","author":"Wang","year":"2025","journal-title":"Research"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","article-title":"Circadian rhythm regulates the function of immune cells and participates in the development of tumors","volume":"10","author":"Zeng","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41698-024-00530-z","article-title":"Molecular mechanisms of tumour development in glioblastoma: An emerging role for the circadian clock","volume":"8","author":"Nelson","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.tcb.2023.11.004","article-title":"The interplay of the circadian clock and metabolic tumorigenesis","volume":"34","author":"Wang","year":"2024","journal-title":"Trends Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Tavsanli, N., Er\u00f6zden, A.A., and \u00c7al\u0131\u015fkan, M. (2024). Evaluation of small-molecule modulators of the circadian clock: Promising therapeutic approach to cancer. Mol. Biol. Rep., 51.","DOI":"10.1007\/s11033-024-09813-x"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the Dependency of Cellular Protein Levels on mRNA Abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cheng, Z., Teo, G., Krueger, S., Rock, T.M., Koh, H.W., Choi, H., and Vogel, C. (2016). Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol. Syst. Biol., 12.","DOI":"10.15252\/msb.20156423"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1083\/jcb.201803063","article-title":"Protein stability of p53 targets determines their temporal expression dynamics in response to p53 pulsing","volume":"218","author":"Hanson","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Faria, R., Viv\u00e9s, E., Boisguerin, P., Sousa, A., and Costa, D. (2021). Development of Peptide-Based Nanoparticles for Mitochondrial Plasmid DNA Delivery. Polymers, 13.","DOI":"10.3390\/polym13111836"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Albuquerque, T., Neves, A.R., Paul, M., Biswas, S., Vuelta, E., Garc\u00eda-Tu\u00f1\u00f3n, I., S\u00e1nchez-Martin, M., Quintela, T., and Costa, D. (2023). A Potential Effect of Circadian Rhythm in the Delivery\/Therapeutic Performance of Paclitaxel-Dendrimer Nanosystems. J. Funct. Biomater., 14.","DOI":"10.3390\/jfb14070362"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Furtado, A., Duarte, A.C., Costa, A.R., Gon\u00e7alves, I., Santos, C.R.A., Gallardo, E., and Quintela, T. (2024). Circadian ABCG2 Expression Influences the Brain Uptake of Donepezil across the Blood\u2013Cerebrospinal Fluid Barrier. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25095014"},{"key":"ref_72","unstructured":"Mo\u0161kon, M. (2025, May 08). GitHub, CosinorPy. Available online: https:\/\/github.com\/mmoskon\/CosinorPy?tab=readme-ov-file."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6130\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:58:59Z","timestamp":1760032739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":72,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136130"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136130","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}